Melittin may be a promising anticancer agent for the treatment of NSCLC, according to the study’s findings, which showed that it inhibited the proliferation, migration, and invasion of NSCLC cells and caused apoptosis via down-regulating the TGF-β-mediated ERK signaling pathway [54]. Here, TGFB1 is linked to non-small cell lung carcinoma.